Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 2001 May;91(5):774–780. doi: 10.2105/ajph.91.5.774

The impact of harm-reduction-based methadone treatment on mortality among heroin users.

M W Langendam 1, G H van Brussel 1, R A Coutinho 1, E J van Ameijden 1
PMCID: PMC1446673  PMID: 11344886

Abstract

OBJECTIVES: The purpose of this study was to investigate the impact of harm-reduction-based methadone programs on mortality among heroin users. METHODS: A prospective cohort investigation was conducted among 827 participants in the Amsterdam Cohort Study. Poisson regression was used to identify methadone maintenance treatment characteristics (dosage, frequency of program attendance, and type of program) that are significantly and independently associated with mortality due to natural causes and overdose. RESULTS: From 1985 to 1996, 89 participants died of natural causes, and 31 died as a result of an overdose. After adjustment for HIV and underweight status, there was an increase in natural-cause mortality among subjects who left methadone treatment (relative risk [RR] = 2.38, 95% confidence interval [CI] = 1.28, 4.55). Leaving treatment was also related to higher overdose mortality, but only among injection drug users (RR = 4.55, 95% CI = 1.89, 10.00). CONCLUSIONS: Harm-reduction-based methadone treatment, in which the use of illicit drugs is tolerated, is strongly related to decreased mortality from natural causes and from overdoses. Provision of methadone in itself, together with social-medical care, appears more important than the actual methadone dosage.

Full Text

The Full Text of this article is available as a PDF (89.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buning E. C., Coutinho R. A., van Brussel G. H., van Santen G. W., van Zadelhoff A. W. Preventing AIDS in drug addicts in Amsterdam. Lancet. 1986 Jun 21;1(8495):1435–1435. doi: 10.1016/s0140-6736(86)91570-9. [DOI] [PubMed] [Google Scholar]
  2. Caplehorn J. R., Dalton M. S., Cluff M. C., Petrenas A. M. Retention in methadone maintenance and heroin addicts' risk of death. Addiction. 1994 Feb;89(2):203–209. doi: 10.1111/j.1360-0443.1994.tb00879.x. [DOI] [PubMed] [Google Scholar]
  3. Darke S., Zador D. Fatal heroin 'overdose': a review. Addiction. 1996 Dec;91(12):1765–1772. doi: 10.1046/j.1360-0443.1996.911217652.x. [DOI] [PubMed] [Google Scholar]
  4. Davoli M., Perucci C. A., Forastiere F., Doyle P., Rapiti E., Zaccarelli M., Abeni D. D. Risk factors for overdose mortality: a case-control study within a cohort of intravenous drug users. Int J Epidemiol. 1993 Apr;22(2):273–277. doi: 10.1093/ije/22.2.273. [DOI] [PubMed] [Google Scholar]
  5. Eskild A., Magnus P., Samuelsen S. O., Sohlberg C., Kittelsen P. Differences in mortality rates and causes of death between HIV positive and HIV negative intravenous drug users. Int J Epidemiol. 1993 Apr;22(2):315–320. doi: 10.1093/ije/22.2.315. [DOI] [PubMed] [Google Scholar]
  6. Fugelstad A., Rajs J., Böttiger M., Gerhardsson de Verdier M. Mortality among HIV-infected intravenous drug addicts in Stockholm in relation to methadone treatment. Addiction. 1995 May;90(5):711–716. doi: 10.1046/j.1360-0443.1995.90571112.x. [DOI] [PubMed] [Google Scholar]
  7. Galli M., Musicco M. Mortality of intravenous drug users living in Milan, Italy: role of HIV-1 infection. COMCAT Study Group. AIDS. 1994 Oct;8(10):1457–1463. doi: 10.1097/00002030-199410000-00013. [DOI] [PubMed] [Google Scholar]
  8. Gearing F. R., Schweitzer M. D. An epidemiologic evaluation of long-term methadone maintenance treatment for heroin addiction. Am J Epidemiol. 1974 Aug;100(2):101–112. doi: 10.1093/oxfordjournals.aje.a112012. [DOI] [PubMed] [Google Scholar]
  9. Ghodse A. H., Sheehan M., Taylor C., Edwards G. Deaths of drug addicts in the United Kingdom 1967-81. Br Med J (Clin Res Ed) 1985 Feb 9;290(6466):425–428. doi: 10.1136/bmj.290.6466.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Grönbladh L., Ohlund L. S., Gunne L. M. Mortality in heroin addiction: impact of methadone treatment. Acta Psychiatr Scand. 1990 Sep;82(3):223–227. doi: 10.1111/j.1600-0447.1990.tb03057.x. [DOI] [PubMed] [Google Scholar]
  11. Hartgers C., Van den Hoek J. A., Coutinho R. A., Van der Pligt J. Psychopathology, stress and HIV-risk injecting behaviour among drug users. Br J Addict. 1992 Jun;87(6):857–865. doi: 10.1111/j.1360-0443.1992.tb01980.x. [DOI] [PubMed] [Google Scholar]
  12. Hulse G. K., English D. R., Milne E., Holman C. D. The quantification of mortality resulting from the regular use of illicit opiates. Addiction. 1999 Feb;94(2):221–229. doi: 10.1046/j.1360-0443.1999.9422216.x. [DOI] [PubMed] [Google Scholar]
  13. Langendam M. W., van Brussel G. H., Coutinho R. A., van Ameijden E. J. Methadone maintenance and cessation of injecting drug use: results from the Amsterdam Cohort Study. Addiction. 2000 Apr;95(4):591–600. doi: 10.1046/j.1360-0443.2000.95459110.x. [DOI] [PubMed] [Google Scholar]
  14. Langendam M. W., van Brussel G. H., Coutinho R. A., van Ameijden E. J. Methadone maintenance treatment modalities in relation to incidence of HIV: results of the Amsterdam cohort study. AIDS. 1999 Sep 10;13(13):1711–1716. doi: 10.1097/00002030-199909100-00015. [DOI] [PubMed] [Google Scholar]
  15. Langendam M. W., van Haastrecht H. J., van Brussel G. H., Reurs H., van den Hoek A. A., Coutinho R. A., van Ameijden E. J. Differentiation in the Amsterdam methadone dispensing circuit: determinants of methadone dosage and site of methadone prescription. Addiction. 1998 Jan;93(1):61–72. doi: 10.1046/j.1360-0443.1998.931617.x. [DOI] [PubMed] [Google Scholar]
  16. Oppenheimer E., Tobutt C., Taylor C., Andrew T. Death and survival in a cohort of heroin addicts from London clinics: a 22-year follow-up study. Addiction. 1994 Oct;89(10):1299–1308. doi: 10.1111/j.1360-0443.1994.tb03309.x. [DOI] [PubMed] [Google Scholar]
  17. Perucci C. A., Davoli M., Rapiti E., Abeni D. D., Forastiere F. Mortality of intravenous drug users in Rome: a cohort study. Am J Public Health. 1991 Oct;81(10):1307–1310. doi: 10.2105/ajph.81.10.1307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Plomp H. N., Van Der Hek H., Adèr H. J. The Amsterdam methadone dispensing circuit: genesis and effectiveness of a public health model for local drug policy. Addiction. 1996 May;91(5):711–721. doi: 10.1046/j.1360-0443.1996.9157117.x. [DOI] [PubMed] [Google Scholar]
  19. Selwyn P. A., Hartel D., Wasserman W., Drucker E. Impact of the AIDS epidemic on morbidity and mortality among intravenous drug users in a New York City methadone maintenance program. Am J Public Health. 1989 Oct;79(10):1358–1362. doi: 10.2105/ajph.79.10.1358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Stenbacka M., Leifman A., Romelsjö A. The impact of methadone on consumption of inpatient care and mortality, with special reference to HIV status. Subst Use Misuse. 1998 Dec;33(14):2819–2834. doi: 10.3109/10826089809059353. [DOI] [PubMed] [Google Scholar]
  21. Vaillant G. E. A 20-year follow-up of New York narcotic addicts. Arch Gen Psychiatry. 1973 Aug;29(2):237–241. doi: 10.1001/archpsyc.1973.04200020065009. [DOI] [PubMed] [Google Scholar]
  22. Ward J., Darke S., Hall W., Mattick R. Methadone maintenance and the human immunodeficiency virus: current issues in treatment and research. Br J Addict. 1992 Mar;87(3):447–453. doi: 10.1111/j.1360-0443.1992.tb01945.x. [DOI] [PubMed] [Google Scholar]
  23. Ward J., Mattick R. P., Hall W. The effectiveness of methadone maintenance treatment: an overview. Drug Alcohol Rev. 1994;13(3):327–335. doi: 10.1080/09595239400185431. [DOI] [PubMed] [Google Scholar]
  24. Zaccarelli M., Gattari P., Rezza G., Conti S., Spizzichino L., Vlahov D., Ippolito G., Lelli V., Valenzi C. Impact of HIV infection on non-AIDS mortality among Italian injecting drug users. AIDS. 1994 Mar;8(3):345–350. doi: 10.1097/00002030-199403000-00008. [DOI] [PubMed] [Google Scholar]
  25. Zador D., Sunjic S., Darke S. Heroin-related deaths in New South Wales, 1992: toxicological findings and circumstances. Med J Aust. 1996 Feb 19;164(4):204–207. doi: 10.5694/j.1326-5377.1996.tb94136.x. [DOI] [PubMed] [Google Scholar]
  26. van Ameijden E. J., Langendam M. W., Coutinho R. A. Dose-effect relationship between overdose mortality and prescribed methadone dosage in low-threshold maintenance programs. Addict Behav. 1999 Jul-Aug;24(4):559–563. doi: 10.1016/s0306-4603(98)00083-5. [DOI] [PubMed] [Google Scholar]
  27. van Haastrecht H. J., van Ameijden E. J., van den Hoek J. A., Mientjes G. H., Bax J. S., Coutinho R. A. Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus (HIV)-positive and HIV-negative drug users. Am J Epidemiol. 1996 Feb 15;143(4):380–391. doi: 10.1093/oxfordjournals.aje.a008752. [DOI] [PubMed] [Google Scholar]
  28. van Haastrecht H. J., van den Hoek J. A., Bardoux C., Leentvaar-Kuypers A., Coutinho R. A. The course of the HIV epidemic among intravenous drug users in Amsterdam, The Netherlands. Am J Public Health. 1991 Jan;81(1):59–62. doi: 10.2105/ajph.81.1.59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. van den Hoek J. A., Coutinho R. A., van Haastrecht H. J., van Zadelhoff A. W., Goudsmit J. Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam. AIDS. 1988 Feb;2(1):55–60. doi: 10.1097/00002030-198802000-00010. [DOI] [PubMed] [Google Scholar]
  30. van den Hoek J. A., van Haastrecht H. J., Coutinho R. A. Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS. Am J Public Health. 1989 Oct;79(10):1355–1357. doi: 10.2105/ajph.79.10.1355. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES